2013
DOI: 10.1177/0333102413483374
|View full text |Cite
|
Sign up to set email alerts
|

The effect of sumatriptan on cephalic arteries: A 3T MR-angiography study in healthy volunteers

Abstract: Aim To explore a possible differential effect of sumatriptan on extracerebral versus cerebral arteries, we examined the superficial temporal (STA), middle meningeal (MMA), extracranial internal carotid (ICAextra), intracranial internal carotid (ICAintra), middle cerebral (MCA) and basilar arteries (BA). Methods The arterial circumferences were recorded blindly using high-resolution magnetic resonance angiography before and after subcutaneous sumatriptan injection (6 mg) in 18 healthy volunteers. Results We fou… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
32
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 33 publications
(33 citation statements)
references
References 28 publications
1
32
0
Order By: Relevance
“…21,22 The acquired MRA data were saved in DICOM format and transferred to separate workstation and analyzed by LKEB-MRA vessel wall analysis software program. 21,22 The acquired MRA data were saved in DICOM format and transferred to separate workstation and analyzed by LKEB-MRA vessel wall analysis software program.…”
Section: Methodsmentioning
confidence: 99%
“…21,22 The acquired MRA data were saved in DICOM format and transferred to separate workstation and analyzed by LKEB-MRA vessel wall analysis software program. 21,22 The acquired MRA data were saved in DICOM format and transferred to separate workstation and analyzed by LKEB-MRA vessel wall analysis software program.…”
Section: Methodsmentioning
confidence: 99%
“…Similar discussions are ongoing for the triptans and gepants. There is no evidence that triptans may enter the human brain in sufficient quantities to exert central pharmacological actions [25,26] and binding of telcagepant within the brain could only be demonstrated after administration of supratherapeutic doses [27]. Thus, structures that are located outside the BBB appear to be more likely therapeutic targets for the CGRP antibodies.…”
mentioning
confidence: 99%
“…12 Arguably, triptans producing symptomatic relief in these patients suggests a key role of the aneurysmatic dilation in the genesis of NH in these patients, or at least the involvement of vascular structures. Triptans are 5-HT1B/1D receptor agonists and produce vasoconstriction of the extracranial vessels (STA among them) in non-migrainous subjects, while relatively sparing the intracranial vessels.…”
Section: Discussionmentioning
confidence: 95%